Pathology & Laboratory Medicine

You are here

News

Dr. Chen-Kiang Receives Leukemia and Lymphoma Society Mantle Cell Lymphoma Research Initiative Award


Selina Chen-Kiang, PhD
Professor of Pathology and Laboratory Medicine

Please join us in congratulating Dr. Selina Chen-Kiang on receiving a Leukemia and Lymphoma Society Mantle Cell Lymphoma Research Initiative Award.
 
Dr. Chen-Kiang is the leader of this multi-project award totaling $2.5M over 5 years, which includes three projects and three cores.
 
In addition to Dr. Chen-Kiang, this grant involves investigators at WCM and Ohio State University including Drs. Peter Martin, Jia Ruan, Kami Maddocks, Olivier Elemento, Lewis Cantley, Jihye Paik, Robert Baiocchi, Giorgio Inghirami, Chris Mason and Karla Ballman.
Over the next 5 years, these investigators will focus on developing new therapies for the treatment of mantle cell lymphoma.  These therapies will be based on a better understanding of the molecular basis of this disease.  In addition, they will define the molecular basis for resistance to pathway-focused therapeutics that are currently being used to treat mantle cell lymphoma. 

Dr. David P. Hajjar Promoted to University Professor

David Hajjar, PhD
University Professor

We are pleased to announce the promotion of David P. Hajjar, PhD to the rank of University Professor. 

The rank of University Professor was authorized by the Cornell University Board of Trustees in April 1957. A University Professor at the Medical College is an individual who is a distinguished and nationally recognized medical scholar who has an extraordinary breadth of scholarly achievement and academic experience.

Congratulations David!!

Dr. Ethel Cesarman Receives 2017 Daedalus Fund for Innovation Award

Ethel Cesarman, PhD
Professor of Pathology and Laboratory Medicine

Please join us in congratulating Dr. Ethel Cesarman on receiving a 2017 Daedalus Fund for Innovation Award of $223,000 over two years.

The WCM Daedalus Fund for Innovation is designed to support work needed to transit important basic science discoveries into industry alliances.

Dr. Cesarman’s laboratory has discovered a nucleoside analogue, 6-ETI, which has activity against malignancies that express adenosine kinase (ADK). Dr. Cesarman will use the support from this award to establish the efficacy of 6-ETI in treating pancreatic and colon adenocarcinoma in pre-clinical mouse models. Proven efficacy in these models will make 6-ETI an attractive licensing target.

Congratulations, Dr. Cesarman!

Weill Cornell Medicine Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464 Fax: (212) 746-8192